These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 28384114

  • 1. Immune Cell Subsets Evaluation as a Predictive Tool for Hepatitis B Infection Outcome and Treatment Responsiveness.
    Kandilarova SM, Georgieva AI, Mihaylova AP, Baleva MP, Atanasova VK, Petrova DV, Popov GT, Naumova EJ.
    Folia Med (Plovdiv); 2017 Mar 01; 59(1):53-62. PubMed ID: 28384114
    [Abstract] [Full Text] [Related]

  • 2. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
    Liu YZ, Hou FQ, Ding P, Ren YY, Li SH, Wang GQ.
    Virol J; 2012 Nov 16; 9():274. PubMed ID: 23158844
    [Abstract] [Full Text] [Related]

  • 3. CD8+CD28- T cells: key cytotoxic players impacting disease pathogenesis in chronic HBV infection.
    Nandi M, Pal S, Ghosh S, Chakraborty BC, Dey D, Baidya A, Shil A, Chattopadhyaya S, Banerjee S, Santra A, Chowdhury A, Datta S.
    Clin Sci (Lond); 2019 Sep 13; 133(17):1917-1934. PubMed ID: 31477625
    [Abstract] [Full Text] [Related]

  • 4. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
    Arasli M, Ustundag Y, Delikanli B, Harmandar F, Buyukuysal C.
    Hepatogastroenterology; 2012 May 13; 59(115):851-7. PubMed ID: 22193343
    [Abstract] [Full Text] [Related]

  • 5. Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B.
    Fei GZ, Sylvan SP, Yao GB, Hellström UB.
    J Viral Hepat; 1999 May 13; 6(3):219-27. PubMed ID: 10607234
    [Abstract] [Full Text] [Related]

  • 6. CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.
    Wongjitrat C, Sukwit S, Chuenchitra T, Seangjaruk P, Rojanasang P, Romputtan P, Srisurapanon S.
    J Med Assoc Thai; 2013 Jan 13; 96 Suppl 1():S54-9. PubMed ID: 23724456
    [Abstract] [Full Text] [Related]

  • 7. A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment.
    Diao H, He J, Zheng Q, Chen J, Cui G, Wei Y, Ye P, Kohanawa M, Li L.
    Immunol Lett; 2014 Jul 13; 160(1):65-71. PubMed ID: 24718278
    [Abstract] [Full Text] [Related]

  • 8. Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients.
    Cao W, Qiu ZF, Li TS.
    World J Gastroenterol; 2011 May 07; 17(17):2191-8. PubMed ID: 21633528
    [Abstract] [Full Text] [Related]

  • 9. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.
    Li J, Han Y, Jin K, Wan Y, Wang S, Liu B, Liu Y, Lu S, Huang Z.
    Virol J; 2011 May 02; 8():199. PubMed ID: 21535873
    [Abstract] [Full Text] [Related]

  • 10. [Changes in lymphocyte surface expression of CD8 and CD38 molecules in peripheral blood of inactive HBsAg carriers following pegylated interferon a-2a therapy].
    Yu HB, Ma LN, Liu YL, Hua W, He ZM, Lu JF, Chen XY.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec 02; 21(12):895-8. PubMed ID: 24636289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ, Chen XF, Chen WL, Chen R, Huang J, Luo XD, Liao JY, Chen XP.
    Eur Rev Med Pharmacol Sci; 2017 Oct 02; 21(20):4675-4679. PubMed ID: 29131246
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Natural Killer Group 2A Expressed on Both Peripheral CD3-CD56+NK Cells and CD3+CD8+T Cells Plays a Pivotal Negative Regulatory Role in the Progression of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
    Yi RT, Niu YH, Liu HL, Zhang TY, Yang YC, Zhang Y, Yin DL, Chen TY, Zhao YR.
    J Interferon Cytokine Res; 2016 Dec 02; 36(12):689-697. PubMed ID: 27828717
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in the proportions of CD4(+)T cell subsets defined by CD127 and CD25 expression during HBV infection.
    Xu HT, Ye J, Chen YB, Zhang LX, Huang JX, Xian JC, Liu L, Peng HL, Li L, Lin M, Huang JH.
    Immunol Invest; 2012 Dec 02; 41(3):290-303. PubMed ID: 22122423
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Difference and significance of peripheral blood T-lymphocyte subsets in patients with chronic hepatitis B and asymptomatic HBV carriers].
    Tian Y, Qiu ZF, Li TS.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 14; 85(47):3354-8. PubMed ID: 16409844
    [Abstract] [Full Text] [Related]

  • 20. Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg.
    Liu N, Liu B, Zhang L, Li H, Chen Z, Luo A, Chen M, Peng M, Yin W, Ren H, Hu P.
    Int Immunopharmacol; 2018 Sep 14; 62():59-66. PubMed ID: 29990695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.